In progress
Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.
Work plan
Work plan
Click on the tabs for more information about the status of each phase in the review process. For more information about how each phase is conducted, please read about the reconsideration process.
Chemicals
- Neonicotinoids
1. Nomination
1. Nomination
Phase status
CompletedNeonicotinoid (acetamiprid, clothianidin, dinotefuran, imidacloprid, thiacloprid, thiamethoxam) active constituents, product registrations and label approvals were nominated for review following identification of new environmental risks in 2019. As a result of the limited use pattern (in companion animals) and formulation (as oral tablets), the registered products and approved active constituent containing nitenpyram are considered to be outside the scope of this review.
2. Prioritisation
2. Prioritisation
Phase status
Completed
3. Scoping and work plan
3. Scoping and work plan
Phase status
CompletedThe scope of the review includes reconsideration of neonicotinoid active constituents, chemical products and labels through assessments related to environment and worker safety.
The review scope document is available in the publication archive tab.
The work plan was first published on 19 November 2019.
4. Notice of reconsideration
4. Notice of reconsideration
Phase status
CompletedThe s 32 notice of reconsideration for active constituents, chemical products and labels for neonicotinoids was published in the Gazette on 19 November 2019.
The s 32 notice of reconsideration was given to holders and chemical coordinators of the states and territories upon commencement of the review on 19 November 2019.
5. Assessment
5. Assessment
Phase status
In ProgressWhen the component risk assessments have been completed, the proposed regulatory decisions will be drafted.
6. Proposed regulatory decision
6. Proposed regulatory decision
Phase status
ForecastedPublication of the proposed regulatory decisions for individual neonicotinoid actives are expected between March 2023 and October 2023.
7. Consultation
7. Consultation
Phase status
ForecastedThe legislated timeframe for consultation following publication of the proposed regulatory decision is 3 months.
8. Final regulatory decision
8. Final regulatory decision
Phase status
ForecastedFollowing the close of the public consultation period on the proposed regulatory decision and consideration of submissions received, the final regulatory decision will be published.
Publication of the final regulatory decisions for all the neonicotinoids is forecast for February 2024.
9. Implementation
9. Implementation
Phase status
ForecastedThe implementation period will begin on the date the final regulatory decision is made.
Publication archive
Publication Archive
| Type | Title | Publication date |
|---|---|---|
| Gazette | Notice of Reconsideration | 19 November 2019 |